Product Name :
UFP-803 TFA
Description:
UFP-803 TFA is a potent urotensin-II receptor (UT) ligand. UFP-803 TFA has lower residual agonist activity, so it may be an important tool for the investigations on the role played by the UT system in physiology and pathology.
CAS:
Molecular Weight:
1175.26
Formula:
C52H65F3N10O14S2
Chemical Name:
(S)-4-(((4R, 7S, 10S, 13S, 16S, 19S)-13-((1H-indol-3-yl)methyl)-10-(2-aminoethyl)-16-benzyl-4-(((S)-1-carboxy-2-methylpropyl)carbamoyl)-7-(4-hydroxybenzyl)-20, 20-dimethyl-6, 9, 12, 15, 18-pentaoxo-1, 2-dithia-5, 8, 11, 14, 17-pentaazacycloicosan-19-yl)amino)-3-amino-4-oxobutanoic acid–2, 2, 2-trifluoroacetic acid (1/1)
Smiles :
CC1(C)SSC[C@H](NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CCN)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H]1NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O.OC(=O)C(F)(F)F
InChiKey:
ODNYPFXZPLBFAS-DZUKYAJKSA-N
InChi :
InChI=1S/C50H64N10O12S2.C2HF3O2/c1-26(2)40(49(71)72)59-47(69)38-25-73-74-50(3,4)41(60-42(64)32(52)23-39(62)63)48(70)57-36(20-27-10-6-5-7-11-27)44(66)56-37(22-29-24-53-33-13-9-8-12-31(29)33)46(68)54-34(18-19-51)43(65)55-35(45(67)58-38)21-28-14-16-30(61)17-15-28;3-2(4,5)1(6)7/h5-17,24,26,32,34-38,40-41,53,61H,18-23,25,51-52H2,1-4H3,(H,54,68)(H,55,65)(H,56,66)(H,57,70)(H,58,67)(H,59,69)(H,60,64)(H,62,63)(H,71,72);(H,6,7)/t32-,34-,35-,36-,37-,38-,40-,41-;/m0./s1
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
UFP-803 TFA is a potent urotensin-II receptor (UT) ligand. UFP-803 TFA has lower residual agonist activity, so it may be an important tool for the investigations on the role played by the UT system in physiology and pathology.|Product information|Molecular Weight: 1175.26|Formula: C52H65F3N10O14S2|Chemical Name: (S)-4-(((4R, 7S, 10S, 13S, 16S, 19S)-13-((1H-indol-3-yl)methyl)-10-(2-aminoethyl)-16-benzyl-4-(((S)-1-carboxy-2-methylpropyl)carbamoyl)-7-(4-hydroxybenzyl)-20, 20-dimethyl-6, 9, 12, 15, 18-pentaoxo-1, 2-dithia-5, 8, 11, 14, 17-pentaazacycloicosan-19-yl)amino)-3-amino-4-oxobutanoic acid–2, 2, 2-trifluoroacetic acid (1/1)|Smiles: CC1(C)SSC[C@H](NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CCN)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H]1NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O.Tusamitamab References OC(=O)C(F)(F)F|InChiKey: ODNYPFXZPLBFAS-DZUKYAJKSA-N|InChi: InChI=1S/C50H64N10O12S2.Panitumumab (anti-EGFR) JAK/STAT Signaling C2HF3O2/c1-26(2)40(49(71)72)59-47(69)38-25-73-74-50(3,4)41(60-42(64)32(52)23-39(62)63)48(70)57-36(20-27-10-6-5-7-11-27)44(66)56-37(22-29-24-53-33-13-9-8-12-31(29)33)46(68)54-34(18-19-51)43(65)55-35(45(67)58-38)21-28-14-16-30(61)17-15-28;3-2(4,5)1(6)7/h5-17,24,26,32,34-38,40-41,53,61H,18-23,25,51-52H2,1-4H3,(H,54,68)(H,55,65)(H,56,66)(H,57,70)(H,58,67)(H,59,69)(H,60,64)(H,62,63)(H,71,72);(H,6,7)/t32-,34-,35-,36-,37-,38-,40-,41-;/m0.PMID:32101103 /s1|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|Products are for research use only. Not for human use.|